SUMMARY A fundamental description of pacemaker systems which are commercially available or in clinical validation is given as a background for their application in a series of 62 consecutive patients presenting over a period of 1 year for permanent cardiac pacing. The patients (23 (37%) sick sinus syndrome, 38 (61%) atrioventricular block, and 1 ventricular tachycardia) were studied electrophysiologically and haemodynamically to allow the appropriate application of a pacemaker system. In sick sinus syndrome, 8 patients had permanent atrial pacing, 14 ventricular pacing, and 1 atrioventricular sequential pacing; in atrioventricular block, 8 patients had atrial synchronous ventricular inhibited pacing and the remaining 30 had ventricular pacing. A high incidence of atrial fibrillation, 9 patients, and abnormal sinus node function, 15 patients, precluded wider use of atrial synchrony. The results show benefit in acute haemodynamic studies of using systems including atrial sensing and/or pacing, and with greater availability of atrioventricular sequential and still more advanced pacemakers with dual sensing as well as dual pacing the majority of patients may be offered this benefit. Permanent, implanted cardiac pacemakers have been used clinically since 1959 (Elmqvist and Senning, 1960). As is common with new treatments, the initial indications for use were very narrow, in this instance intended primarily for ventricular stimulation in cases of complete atrioventricular block with Adams-Stokes seizures. These early pacing systems maintained a constant regular cardiac rhythm by stimulating the ventricles asynchronously at a fixed rate, usually 70 pulses per minute. As a fuller understanding of cardiac pacing was realised, indications for use expanded to include management of symptomatic bradyarrhythmias, tachyarrhythmias, and restoration of optimal haemodynamics. As a result, the operational types of artificial pacemakers evolved so that there now exists an armamentarium of atrial and ventricular pacemaker systems, each appropriate to certain pathological situations within a broad range of cardiac diseases.